News Headlines Article

Pfizer tops Wall Street forecasts, raises guidance
USA Today

Pfizer’s (PFE) first-quarter financial results topped Wall Street forecasts Tuesday, boosted by the U.S. pharmaceutical giant’s recent Hospira acquisition, strengthened medication sales and improving foreign exchange rates.

The New York-based company raised its financial guidance for 2016, forecasting an upbeat year roughly one month after being forced to scrap a planned $160 billion merger deal with Ireland rival Allergan (AGN).